DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Mota JM, Sousa LG, Braghiroli MI. et al.
Pembrolizumab for metastatic adrenocortical carcinoma with high mutational
burden: Two case reports.
Medicine (Baltimore) 2018;
97: e13517
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.